Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical net income
Net income is the profit left for shareholders after every expense, interest and tax.
Ocean Biomedical's net income for the twelve months ending Mar 31, 2025 was -$30.72M. For fiscal 2024 it was -$9.48M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$9.48M | – |
| FY2023 | Dec 31, 2023 | -$114.47M | – |
| FY2022 | Dec 31, 2022 | -$17.36M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -$8.24M | -163.4% |
| Q4 FY2024 | Dec 31, 2024 | -$1.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$17.23M | – |
| Q1 FY2024 | Mar 31, 2024 | $13.00M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.86M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$72.09M | – |
| Q4 FY2022 | Dec 31, 2022 | -$983.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.67M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.33M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.38M | – |
| Q3 FY2021 | Sep 30, 2021 | -$42.63K | – |
See a number that looks wrong?